APA

Gersuk G. M., Carmel R., Pattamakom S., Challita P. M., Rabinowitz A. P. & Pattengale P. K. (19930819). Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity. : Natural immunity.

Chicago

Gersuk G M, Carmel R, Pattamakom S, Challita P M, Rabinowitz A P and Pattengale P K. 19930819. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity. : Natural immunity.

Harvard

Gersuk G. M., Carmel R., Pattamakom S., Challita P. M., Rabinowitz A. P. and Pattengale P. K. (19930819). Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity. : Natural immunity.

MLA

Gersuk G M, Carmel R, Pattamakom S, Challita P M, Rabinowitz A P and Pattengale P K. Quantitative and functional studies of impaired natural killer (NK) cells in patients with myelofibrosis, essential thrombocythemia, and polycythemia vera. I. A potential role for platelet-derived growth factor in defective NK cytotoxicity. : Natural immunity. 19930819.